相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Changes in Gastrointestinal Hormone Responses, Insulin Sensitivity, and Beta-Cell Function Within 2 Weeks After Gastric Bypass in Non-diabetic Subjects
S. H. Jacobsen et al.
OBESITY SURGERY (2012)
Incretin physiology beyond glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide: cholecystokinin and gastrin peptides
J. F. Rehfeld
ACTA PHYSIOLOGICA (2011)
Combination Therapy With a Dipeptidyl Peptidase-4 Inhibitor and a Proton Pump Inhibitor Induces beta-Cell Neogenesis From Adult Human Pancreatic Duct Cells Implanted in Immunodeficient Mice
Wilma L. Suarez-Pinzon et al.
CELL TRANSPLANTATION (2011)
GLP-1 receptor agonists and HBA1c target of <7% in type 2 diabetes: meta-analysis of randomized controlled trials
K. Esposito et al.
CURRENT MEDICAL RESEARCH AND OPINION (2011)
The human glucagon-like peptide-1 analogue liraglutide preserves pancreatic beta cells via regulation of cell kinetics and suppression of oxidative and endoplasmic reticulum stress in a mouse model of diabetes
M. Shimoda et al.
DIABETOLOGIA (2011)
Gastrin Treatment Stimulates β-Cell Regeneration and Improves Glucose Tolerance in 95% Pancreatectomized Rats
Noelia Tellez et al.
ENDOCRINOLOGY (2011)
Early-Life Origins of Type 2 Diabetes: Fetal Programming of the Beta-Cell Mass
Bernard Portha et al.
EXPERIMENTAL DIABETES RESEARCH (2011)
Reduced Proliferation and a High Apoptotic Frequency of Pancreatic Beta Cells Contribute to Genetically-determined Diabetes Susceptibility of db/db BKS Mice
R. Puff et al.
HORMONE AND METABOLIC RESEARCH (2011)
Emerging therapies in the treatment of 'diabesity': beyond GLP-1
George Tharakan et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2011)
Treatment with a proton pump inhibitor improves glycaemic control in Psammomys obesus, a model of type 2 diabetes
T. B. Bodvarsdottir et al.
DIABETOLOGIA (2010)
Stereological assessment of pancreatic beta-cell mass development in male Zucker Diabetic Fatty (ZDF) rats: correlation with pancreatic beta-cell function
Sarah Juel Paulsen et al.
JOURNAL OF ANATOMY (2010)
Characterization of β-Cell Mass and Insulin Resistance in Diet-induced Obese and Diet-resistant Rats
Sarah J. Paulsen et al.
OBESITY (2010)
Combination treatment of db/db mice with exendin-4 and gastrin preserves β-cell mass by stimulating β-cell growth and differentiation
Motoyuki Tamaki et al.
JOURNAL OF DIABETES INVESTIGATION (2010)
Prospective study of gut hormone and metabolic changes after adjustable gastric banding and Roux-en-Y gastric bypass
J. Korner et al.
INTERNATIONAL JOURNAL OF OBESITY (2009)
A new glucagon and GLP-1 co-agonist eliminates obesity in rodents
Jonathan W. Day et al.
NATURE CHEMICAL BIOLOGY (2009)
Reversal of Type 2 Diabetes Mellitus and Improvements in Cardiovascular Risk Factors After Surgical Weight Loss in Adolescents
Thomas H. Inge et al.
PEDIATRICS (2009)
Combination therapy with glucagon-like peptide-1 and gastrin induces beta-cell neogenesis from pancreatic duct cells in human islets transplanted in immunodeficient diabetic mice
Wilma L. Suarez-Pinzon et al.
CELL TRANSPLANTATION (2008)
Combination Therapy With Glucagon-Like Peptide-1 and Gastrin Restores Normoglycemia in Diabetic NOD Mice
Wilma L. Suarez-Pinzon et al.
DIABETES (2008)
Beta cell mass in diabetes: a realistic therapeutic target?
J. J. Meier
DIABETOLOGIA (2008)
Lessons from the gastrin knockout mice
Lennart Friis-Hansen
REGULATORY PEPTIDES (2007)
The endoproteolytic maturation of progastrin and procholecystokinin
Jens F. Rehfeld
JOURNAL OF MOLECULAR MEDICINE-JMM (2006)
Sustained beta cell apoptosis in patients with long-standing type 1 diabetes: indirect evidence for islet regeneration?
JJ Meier et al.
DIABETOLOGIA (2005)
Combination therapy with epidermal growth factor and gastrin increases β-cell mass and reverses hyperglycemia in diabetic NOD mice
WL Suarez-Pinzon et al.
DIABETES (2005)
Combination therapy with epidermal growth factor and gastrin induces neogenesis of human islet β-cells from pancreatic duct cells and an increase in functional β-cell mass
WL Suarez-Pinzon et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Exenatide (Exendin-4) improves insulin sensitivity and β-cell mass in insulin-resistant obese fa/fa Zucker rats independent of glycemia and body weight
BR Gedulin et al.
ENDOCRINOLOGY (2005)
Twelve- and 52-week efficacy of the dipeptidyl peptidase IV inhibitor LAF237 in metformin-treated patients with type 2 diabetes
B Ahrén et al.
DIABETES CARE (2004)
GLP-1 derivative liraglutide in rats with β-cell deficiencies:: influence of metabolic state on β-cell mass dynamics
J Sturis et al.
BRITISH JOURNAL OF PHARMACOLOGY (2003)
Increased islet volume but unchanged islet number in ob/ob mice
T Bock et al.
DIABETES (2003)
Glucagon-like peptide 1 receptor agonist ZP10A increases insulin mRNA expression and prevents diabetic progression in db/db mice
C Thorkildsen et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes
AE Butler et al.
DIABETES (2003)
Minireview:: Secondary β-cell failure in type 2 diabetes -: A convergence of glucotoxicity and lipotoxicity
V Poitout et al.
ENDOCRINOLOGY (2002)
Gastrin stimulates beta-cell neogenesis and increases islet mass from transdifferentiated but not from normal exocrine pancreas tissue
I Rooman et al.
DIABETES (2002)
Mitogenic effect of gastrin and expression of gastrin receptors in duct-like cells of rat pancreas
I Rooman et al.
GASTROENTEROLOGY (2001)
分享论文
